Učitavanje...
Treatment outcome of intravenous artesunate in patients with severe malaria in the Netherlands and Belgium
BACKGROUND: Intravenous (IV) artesunate is the treatment of choice for severe malaria. In Europe, however, no GMP-manufactured product is available and treatment data in European travellers are scarce. Fortunately, artesunate became available in the Netherlands and Belgium through a named patient pr...
Spremljeno u:
| Glavni autori: | , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2012
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3364861/ https://ncbi.nlm.nih.gov/pubmed/22462806 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2875-11-102 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|